Carregant...

17-DMAG对EGFR-TKI耐药的非小细胞肺癌细胞株A549和H1975作用的研究

BACKGROUND AND OBJECTIVE: In the clinical treatment of patients with non-small cell lung cancer (NSCLC), the primary and acquired resistance of epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) limits its clinical application, this need to explore new strategy or method to overco...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Zhongguo Fei Ai Za Zhi
Format: Artigo
Idioma:Inglês
Publicat: 中国肺癌杂志编辑部 2014
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6000355/
https://ncbi.nlm.nih.gov/pubmed/25404267
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3779/j.issn.1009-3419.2014.11.02
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!